[1] Sun W, Gaykalova DA, Ochs MF,et al. Activation of the NOTCH pathway in head and neck cancer [J]. Cancer Res, 2014, 74(4):1091-1104. [2] Takahashi H, Yanamoto S, Yamada S, et al. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases [J]. Int J Oral Maxillofac Surg, 2014, 43(6):680-685. [3] Nobuharu Y, Kazumichi S, Tomohiro Y, et al. A 5-year activity report from the oral cancer center, Tokyo dental college [J]. Bull Tokyo Dent Coll, 2013, 54(4): 265-273. [4] 何黎明,郭新程,陶山松.CCND1、ORAOV1、ERCC1在舌鳞状细胞癌中的表达和临床意义[J].口腔医学研究,2015,31(6):597-600. [5] 吕珊珊,魏秀峰,孙鑫.Pinx1在口腔鳞癌中的表达及意义[J].口腔医学研究,2016,32(10):1064-1066. [6] 王贞超,杨开迆.P53基因的生物信息学分析[J].世界最新医学信息文摘,2017,17(2):34. [7] Chu EC, Tamawski AS. PTEN regulatory functions in tumor suppression and cell biology [J]. Med Sci Monit, 2014, 10(10):235-241. [8] Roye GD ,Myers RB, Brown D, et al. CD44 expression in dys-plastic epithelic and squamous-cell carcinoma of the esophagus [J]. Int J Cancer, 2006, 69:254-258. [9] Clark SW, Fee BE, Cleveland JL. Misexpression of the eyes absent family triggers the apoptotic program [J]. J Biol Chem, 2002, 277 (5) :3560-3567. [10] Xu PX, Adams J, Peters H, et al. Eya1- deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia [J]. Nat Genet, 1999, 23(1): 113-117. [11] Miller SJ, Lan ZD, Hardiman A, et al. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis [J]. Oncogene, 2010, 29 (3): 368-379. [12] Kim JJ, Grady WM. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations [J]. Ann Surg Oncol, 2011, 18: 2338–2347. [13] Osborn NK, Zou H, Molina JR, et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia [J]. Clin Gastroenterol Hepatol, 2006, 4(2):212-218. [14] Kim SJ, Tae CH, Hong SN, et al. EYA4 acts as a new tumor suppressor gene in colorectal cancer [J]. Mol Carcinog, 2015, 54(12):1748-1757. [15] Hou X, Peng JX, Hao XY, et al.DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma [J]. Ann Surg Oncol, 2014, 21(12):3891-3899. [16] Hao XY, Cai JP, Liu X, et al. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma [J]. Chin J Cancer, 2016, 35(1):70. [17] Zhang SK, Zheng RS, Chen Q, et al. Oral cancer incidence and mortalityin China,2011 [J]. Chin J Cancer Res, 2015, 27(1):44-51. [18] Tadjuidje E, Hegde RS. The eyas absent proteins in development and disease [J]. Cell Mol Life Sci, 2013, 70(11):1897-1913. [19] Towle R, Truong D, Garnis C. Epigenetic mediated silencing of EYA4 contributes to tumorigenesis in oral dysplastic cells [J]. Genes Chromosomes Cancer, 2016, 55(7):568-576. [20] Zou H, Osborn NK, Harrington JJ, et al. Frequent methylation of eyas absent 4 gene in Barrett’s esophagus and esophageal adenocarcinoma [J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(4):830-834. |